Recombinant modified vaccinia virus Ankara expressing glycoprotein E2 of Chikungunya virus protects AG129 mice against lethal challenge.

• Үндсэн зохиолчид: Petra van den Doel (Зохиогч), Asisa Volz (Зохиогч), Jouke M Roose (Зохиогч), Varsha D Sewbalaksing (Зохиогч), Gorben P Pijlman (Зохиогч), Ingeborg van Middelkoop (Зохиогч), Vincent Duiverman (Зохиогч), Eva van de Wetering (Зохиогч), Gerd Sutter (Зохиогч), Albert D M E Osterhaus (Зохиогч), Byron E E Martina (Зохиогч)
• Формат: Ном
• Хэвлэсэн: Public Library of Science (PLoS), 2014-09-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

Chikungunya virus (CHIKV) infection is characterized by rash, acute high fever, chills, headache, nausea, photophobia, vomiting, and severe polyarthralgia. There is evidence that arthralgia can persist for years and result in long-term discomfort. Neurologic disease with fatal outcome has been docum...